COMPUS Communiqué — Vol. 5, No. 6

December 8, 2009

In This Issue

Executive Summary for Self-Monitoring of Blood Glucose

The Canadian Agency for Drugs and Technologies in Health (CADTH) has released an Executive Summary for the Self-Monitoring of Blood Glucose (SMBG) topic. This Executive Summary guides readers through each component of the project, including the clinical and cost-effectiveness evidence, key messages that address practice gaps, and development of user-friendly intervention tools.

CADTH Article in the Canadian Journal of Diabetes

Don’t miss the December issue of the Canadian Journal of Diabetes, featuring an in-depth article entitled “Current Utilization and Expenditure on Blood Glucose Test Strips in Canada.”

Online CME Course on Proton Pump Inhibitors

A new online continuing medical education (CME) course is available entitled “PPIs and the Treatment of GERD, Dyspepsia and NSAID-associated Peptic Ulcer Disease.”

The course was developed by MDcme.ca using CADTH’s series of Optimal Therapy Reports on proton pump inhibitors (PPIs), including clinical and cost-effectiveness evidence and recommendations for optimal prescribing and use. The launch of this course is the latest example of how CADTH provides stakeholders with credible, evidence-based information that supports patient care and the effective use of health care resources.

The aim of the course is to increase awareness among physicians and other health care practitioners of the optimal use of PPIs in the management of upper gastrointestinal conditions. The course is available free of charge to registered users of MDcme.ca and has been accredited for MainPro M1 for up to 1.5 credit hours.

Visit the PPI section of CADTH’s website for complete information about the PPI topic, including scientific reports and tools to help decision-makers put evidence into practice.

CADTH Creates New Award of Excellence

CADTH is pleased to announce the creation of a new Award of Excellence that will recognize individuals whose outstanding achievements have advanced the fields of health technology assessment, evidence-based drug reviews, or optimal technology use in Canada. The award recipient will receive complimentary travel, accommodation, and registration to attend and speak at the 2010 CADTH Symposium. Visit our website for more information about the eligibility criteria and nomination process. All nominations must be received by January 29, 2010.

Tell Us How CADTH Products Are Being Used

We always want to hear about ways that CADTH research, tools, and services are influencing clinical practice, improving policies, and affecting patient outcomes. If you have a story to share about the impact of CADTH work in your organization, we want to hear it. Contact your local Liaison Officer to share your impact stories.

Feedback

We welcome your feedback. Tell us what you think of the COMPUS Communiqué.